SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-077530
Filing Date
2024-06-26
Accepted
2024-06-25 20:30:50
Documents
11
Period of Report
2024-06-25
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Document Format Files

Seq Description Document Type Size
1 8-K eftr-20240625.htm   iXBRL 8-K 46898
  Complete submission text file 0000950170-24-077530.txt   198153

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eftr-20240625.xsd EX-101.SCH 49788
15 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20240625_htm.xml XML 6392
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 241070381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)